Codexis (CDXS) Net Cash Flow (2010 - 2026)
Codexis' (CDXS) quarterly Net Cash Flow came in at -$14.3 million in Q1 2026, down 1412.18% year-on-year from $1.1 million in Q1 2025, and down 154.94% quarter-over-quarter from $26.0 million in Q4 2025.
Codexis (CDXS) Net Cash Flow (2010 - 2026) Analysis & Trends
Codexis' Net Cash Flow history runs 17 years deep, the most recent figure standing at -$14.3 million for Q1 2026.
- On a quarterly basis, Net Cash Flow fell 1412.18% year-over-year to -$14.3 million in Q1 2026; TTM through Mar 2026 was $18.7 million, a 147.11% increase from a year earlier, with the FY2025 full-year figure at $32.1 million, up 169.88% from the prior year.
- Net Cash Flow retreated to -$14.3 million in Q1 2026 per CDXS's latest filing, from $26.0 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $26.0 million in Q4 2025 and bottomed at -$39.5 million in Q2 2024.
- The 5-year median for Net Cash Flow is -$7.1 million (2024), against an average of -$4.7 million.
- Across the five-year window, Net Cash Flow jumped 320.93% in 2022 and sank 1412.18% in 2026, its largest moves.
- Year by year, Net Cash Flow stood at $5.3 million in 2022, then tumbled by 287.8% to -$9.9 million in 2023, then sank by 83.22% to -$18.2 million in 2024, then soared by 242.78% to $26.0 million in 2025, then plunged by 154.94% to -$14.3 million in 2026.
- Per Business Quant, the three latest CDXS Net Cash Flow figures stand at -$14.3 million (Q1 2026), $26.0 million (Q4 2025), and -$1.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 224.46 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Codexis | 180.63 Mn | 115.49 Mn | 13.18 Mn | -14.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.28 Mn |
| Mar 31, 2026 | -14.28 Mn |
| Dec 31, 2025 | 25.99 Mn |
| Dec 31, 2025 | 25.99 Mn |
| Sep 30, 2025 | -1.43 Mn |
| Sep 30, 2025 | -1.43 Mn |
| Jun 30, 2025 | 8.44 Mn |
| Jun 30, 2025 | 8.44 Mn |
| Mar 31, 2025 | -944,000.00 |
| Mar 31, 2025 | -944,000.00 |
| Dec 31, 2024 | -18.20 Mn |
| Dec 31, 2024 | -18.20 Mn |
| Sep 30, 2024 | 18.85 Mn |
| Sep 30, 2024 | 18.85 Mn |
| Jun 30, 2024 | -39.45 Mn |
| Jun 30, 2024 | -39.45 Mn |
| Mar 31, 2024 | -7.07 Mn |
| Mar 31, 2024 | -7.07 Mn |
| Dec 31, 2023 | -9.93 Mn |
| Dec 31, 2023 | -9.93 Mn |